HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

TL 1

from Talaromyces luteus; structure given in first source

Also Known As:

TL-1

Networked: 20 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - TL 1: 20
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - TL 1: 20

Experts

1.	Lee, Huei: 3 articles (09/2017 - 08/2008)
2.	Lin, Po-Lin: 2 articles (09/2017 - 05/2016)
3.	Wu, De-Wei: 2 articles (09/2017 - 05/2016)
4.	Cheng, Ya-Wen: 2 articles (05/2016 - 08/2008)
5.	Eerenstein, Simone E J: 1 article (01/2020)
6.	Jansen, Femke: 1 article (01/2020)
7.	Leemans, C René: 1 article (01/2020)
8.	Lissenberg-Witte, Birgit I: 1 article (01/2020)
9.	Verdonck-de Leeuw, Irma M: 1 article (01/2020)
10.	van Uden-Kraan, Cornelia F: 1 article (01/2020)

Related Diseases

1.	B-Cell Lymphoma (Lymphoma, B Cell) 07/05/2017 - "In the present study, we investigated whether CADM1 is associated with cell-cell interaction between several human lymphoma cell lines and macrophages.CADM1 expression was observed in the ATLL cell lines, ATN-1, ATL-T, and ATL-35T, and in the B cell lymphoma cell lines, TL-1, DAUDI, and SLVL, using western blotting. " 09/17/2016 - "Based on integrated analyses, CLBL-1 was classified as B-cell lymphoma, Ema and TL-1 as T-cell lymphoma, and UL-1 as T-cell acute lymphoblastic leukemia. "
2.	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 07/05/2017 - "In the present study, we investigated whether CADM1 is associated with cell-cell interaction between several human lymphoma cell lines and macrophages.CADM1 expression was observed in the ATLL cell lines, ATN-1, ATL-T, and ATL-35T, and in the B cell lymphoma cell lines, TL-1, DAUDI, and SLVL, using western blotting. "
3.	Lymphoma (Lymphomas) 07/05/2017 - "In the present study, we investigated whether CADM1 is associated with cell-cell interaction between several human lymphoma cell lines and macrophages.CADM1 expression was observed in the ATLL cell lines, ATN-1, ATL-T, and ATL-35T, and in the B cell lymphoma cell lines, TL-1, DAUDI, and SLVL, using western blotting. "
4.	Type 2 Diabetes Mellitus (MODY) 08/01/2018 - "Nineteen (76%) assessed leukocyte telomere length (LTL) of which 15 found associations between air pollution and shorter TL, 2 with longer TL, 1 had mixed results, and a study of patients with type 2 diabetes found non-significant associations with TL. "
5.	Leukemia 04/01/1982 - "Results suggest that on leukemia cells from Tlaa mice, as previously reported for thymocytes from these mice, all the alloantiserum-defined TL specificities (TL.1, 2, 3, 5, 6) as well as the specificity defined by the monoclonal antibody (TL.m3) are carried by a single molecular species. " 11/01/1981 - "Analysis of the TL product on ERLD leukemia cells (TL phenotype, TL.1,2,4) indicates a single TL glycoprotein species with the TL.4 determinant (restricted to leukemias of Tlab and Tlac haplotypes) coexisting on the same glycoprotein as the Tl.1 determinant (normally expressed by thymocytes of Tlaa haplotype). " 08/01/1975 - "RADA-1 cells [H-2a thy-1b; thymus-leukemia (TL) 1, 2, 3], a radiation-induced murine leukemia cell line maintained by serial transfer in histocompatible recipients, resisted lysis by guinea pig complement (GPC) and TL 1, 3; TL 2; or TL 1, 2, 3 antiserum. " 08/01/1975 - "RADA-1 cells (H-2a), a murine leukemia cell line maintained by serial transfer in histocompatible recipients expressing thymus-leukemia (TL) 1, 2, 3 antigenic determinants, resisted the cytotoxic effects of guinea pig complement (GPC) and TL antiserum. "

Related Drugs and Biologics

1.	Complement System Proteins (Complement)
2.	Interleukin-6 (Interleukin 6)
3.	Vaccines
4.	RNA (Ribonucleic Acid)
5.	Glycoproteins (Glycoprotein)
6.	Nitroglycerin (Dynamite)
7.	DNA (Deoxyribonucleic Acid)
8.	Epitopes
9.	Monoclonal Antibodies

Related Therapies and Procedures

1.	Laryngectomy